VERONA PHARMA PLC - ADR(NASDAQ:VRNA) stock News

VRNA Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Zacks Investment Research

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy

4 days ago - By: Zacks Investment Research - Mentions: JNJ MRK UTHR

Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?

4 days ago - By: Zacks Investment Research - Mentions: MRK MRNA SMMT

Merck Stock Down 4% Since Q2 Results: How to Play the Stock

15 days ago - By: The Motley Fool - Mentions: MSTR SMCI MRK

Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $135,000 Today

17 days ago - By: Zacks Investment Research - Mentions: AZN MRK

Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed

a month ago - By: Benzinga

Is the Market Bullish or Bearish on Verona Pharma?

a month ago - By: Zacks Investment Research - Mentions: EVLV

Best Momentum Stock to Buy for July 7th

a month ago - By: Zacks Investment Research - Mentions: TD PRM

New Strong Buy Stocks for July 7th

a month ago - By: The Motley Fool - Mentions: MRK

Does This Move Make Merck Stock a Buy?

a month ago - By: Halper Sadeh LLC - Mentions: DALN RGLD

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, DALN, RGLD on Behalf of Shareholders

a month ago - By: Zacks Investment Research - Mentions: VIPS FUTU ALKT

Weathering Market Uncertainty? Bet on VIPS, ALKT, FUTU & VRNA Now

2 months ago - By: Benzinga - Mentions: GILD SMLR HIMS

4 Health Care Stocks With Whale Alerts In Today's Session

a month ago - By: Yahoo Finance - Mentions: MRK

Verona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer

a month ago - By: Halper Sadeh LLC - Mentions: KLG MGRM SONN

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, KLG, MRGM, SONN on Behalf of Shareholders

a month ago - By: Kahn Swick & Foti, LLC

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA

a month ago - By: Yahoo Finance - Mentions: MRK

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition

a month ago - By: Yahoo Finance - Mentions: MRK

Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck

a month ago - By: Yahoo Finance - Mentions: NVDA HG=F SBUX CRWV ...

Stock market today: Dow, S&P 500, Nasdaq jump as Nvidia's surge to milestone boosts tech

a month ago - By: Halper Sadeh LLC

VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders

a month ago - By: Yahoo Finance - Mentions: NVDA SBUX HG=F CRWV ...

Stock market today: Dow, S&P 500, Nasdaq edge higher as Nvidia's market cap hits $4T, Trump unveils more tariff letters

a month ago - By: Brodsky & Smith LLC - Mentions: OLO GNTY MRC MRK ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verona Pharma plc (Nasdaq - VRNA), Olo Inc. (NYSE - OLO), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC)

a month ago - By: Investor's Business Daily - Mentions: MRK

Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma

a month ago - By: Merck & Co., Inc. - Mentions: MRK

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade

2 months ago - By: Yahoo Finance

VERONA PHARMA PLC - ADR (VRNA) Stock News

VRNA Latest News, Press Relases and Analysis

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy

Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?

Merck Stock Down 4% Since Q2 Results: How to Play the Stock

Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $135,000 Today

Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed

Is the Market Bullish or Bearish on Verona Pharma?

Best Momentum Stock to Buy for July 7th

New Strong Buy Stocks for July 7th

Does This Move Make Merck Stock a Buy?

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, DALN, RGLD on Behalf of Shareholders

Weathering Market Uncertainty? Bet on VIPS, ALKT, FUTU & VRNA Now

4 Health Care Stocks With Whale Alerts In Today's Session

Verona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, KLG, MRGM, SONN on Behalf of Shareholders

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition

Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck

Stock market today: Dow, S&P 500, Nasdaq jump as Nvidia's surge to milestone boosts tech

VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders

Stock market today: Dow, S&P 500, Nasdaq edge higher as Nvidia's market cap hits $4T, Trump unveils more tariff letters

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verona Pharma plc (Nasdaq - VRNA), Olo Inc. (NYSE - OLO), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC)

Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade

Verona Pharma price target raised to $160 from $76 at Piper Sandler